Skip to main content
Top

Cancer and Metastasis Reviews

Issue 2/2022

Microbiome, Carcinogenesis and Cancer Metastasis

Content (17 Articles)

Preface

Misako Nagasaka, Grace Chen

COMMENTARY

The paradoxical role of inositol in cancer: a consequence of the metabolic state of a tumor

Kendall C. Case, Michael W. Schmidtke, Miriam L. Greenberg

Open Access Neuroblastoma COMMENTARY

Targeting lipid metabolism in cancer: neuroblastoma

Massimiliano Agostini, Gerry Melino, Bola Habeb, Jorgelina M. Calandria, Nicolas G. Bazan

Open Access Melanoma

The cure from within? a review of the microbiome and diet in melanoma

Priyanka Kumar, Danielle Brazel, Julia DeRogatis, Jennifer B. Goldstein Valerin, Katrine Whiteson, Warren A. Chow, Roberto Tinoco, Justin T. Moyers

Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis

Tarang Sharma, Ashna Gupta, Ravi Chauhan, Ajaz A. Bhat, Sabah Nisar, Sheema Hashem, Sabah Akhtar, Aamir Ahmad, Mohammad Haris, Mayank Singh, Shahab Uddin

Inflammatory bowel disease and carcinogenesis

Hiroko Nagao-Kitamoto, Sho Kitamoto, Nobuhiko Kamada

Connecting the Human Microbiome and Pancreatic Cancer

Rachel E. Sexton, Md Hafiz Uddin, Sahar Bannoura, Husain Yar Khan, Yousef Mzannar, Yiwei Li, Amro Aboukameel, Mohammad Najeeb Al-Hallak, Bayan Al-Share, Amr Mohamed, Misako Nagasaka, Bassel El-Rayes, Asfar S. Azmi

Correction to: Connecting the human microbiome and pancreatic cancer

Rachel E. Sexton, Md Hafz Uddin, Sahar Bannoura, Husain Yar Khan, Yousef Mzannar, Yiwei Li, Amro Aboukameel, Mohammad Najeeb Al-Hallak, Bayan Al-Share, Amr Mohamed, Misako Nagasaka, Bassel El-Rayes, Asfar S. Azmi

Metastasis Non-Thematic Review

Nanotechnology-aided advancement in the combating of cancer metastasis

Leela Rani Avula, Piotr Grodzinski

Metastasis Non-Thematic Review

Heterogeneity and tumor evolution reflected in liquid biopsy in metastatic breast cancer patients: a review

Stephanie Kavan, Torben A. Kruse, Marianne Vogsen, Malene G. Hildebrandt, Mads Thomassen

Non-Thematic Review

Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux

Brandon C. Jones, Paula R. Pohlmann, Robert Clarke, Surojeet Sengupta

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine